1 Result for "

CCDC6-RETV804M

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "CCDC6-RETV804M" in MCE Product Catalog:

Cat. No.: HY-189268
Target:  

RET

Research Areas:  

Endocrinology Cancer

RET-IN-36 is an orally active RET kinase inhibitor. RET-IN-36 overcomes gatekeeper and solvent front resistance mutations and inhibits the proliferation of cells expressing RET G810C and RET V804M mutants by suppressing RET phosphorylation and SHC downstream signaling. RET-IN-36 can be used for research on RET-mutant cancers, medullary thyroid cancer, papillary thyroid cancer, and non-small cell lung cancer .
loading...
    loading...